ProQR Therapeutics (PRQR) Change in Cash (2013 - 2022)
ProQR Therapeutics recorded quarterly Change in Cash of -$4.1 million in Q4 2022, up 93.1% quarter-over-quarter from -$59.9 million in Q3 2022, and down 111.82% year-over-year from $35.0 million in Q4 2021.
ProQR Therapeutics' Change in Cash history runs 10 years deep, the most recent figure standing at -$4.1 million for Q4 2022.
- In Q4 2022, Change in Cash fell 111.82% year-over-year to -$4.1 million; the TTM figure through Dec 2022 stood at -$104.3 million (down 179.81% YoY), while the FY2025 annual figure was -$64.8 million, down 303.35% from the prior year.
- Change in Cash came in at -$4.1 million for Q4 2022 at ProQR Therapeutics, up from -$59.9 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $93.9 million in Q3 2018 to a low of -$59.9 million in Q3 2022.
- A 5-year average of $4.9 million and a median of -$5.3 million in 2018 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash soared 4347931095.84% in 2018 and plunged 119027791.96% in 2019, its largest moves.
- ProQR Therapeutics' Change in Cash stood at -$9312.7 in 2018, then surged by 451869.13% to $42.1 million in 2019, then plunged by 133.09% to -$13.9 million in 2020, then jumped by 351.13% to $35.0 million in 2021, then plunged by 111.82% to -$4.1 million in 2022.
- According to Business Quant data, Change in Cash over the past three periods registered -$4.1 million, -$59.9 million, and -$16.5 million for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -4.13 Mn |
| Sep 30, 2022 | -59.86 Mn |
| Jun 30, 2022 | -16.47 Mn |
| Mar 31, 2022 | -23.85 Mn |
| Dec 31, 2021 | 34.96 Mn |
| Sep 30, 2021 | 18.08 Mn |
| Jun 30, 2021 | 88.29 Mn |
| Mar 31, 2021 | -10.62 Mn |
| Dec 31, 2020 | -13.92 Mn |
| Sep 30, 2020 | 3.71 Mn |
| Jun 30, 2020 | -11.39 Mn |
| Mar 31, 2020 | -16,170.50 |
| Dec 31, 2019 | 42.07 Mn |
| Sep 30, 2019 | -10.12 Mn |
| Jun 30, 2019 | -12.54 Mn |
| Mar 31, 2019 | -13.76 Mn |
| Dec 31, 2018 | -9,312.65 |
| Sep 30, 2018 | 93.85 Mn |
| Jun 30, 2018 | -6.53 Mn |
| Mar 31, 2018 | 11.56 |
| Dec 31, 2017 | 10,362.58 |
| Sep 30, 2017 | -2.16 |
| Jun 30, 2017 | -9.59 Mn |
| Mar 31, 2017 | 7,112.66 |
| Dec 31, 2016 | -39.27 Mn |
| Sep 30, 2016 | -12,518.01 |
| Dec 31, 2015 | -26.22 Mn |
| Sep 30, 2015 | -7,028.53 |
| Mar 31, 2015 | -6.52 Mn |
| Dec 31, 2014 | -6.85 Mn |
| Sep 30, 2014 | 100.35 Mn |
| Mar 31, 2014 | -2.89 Mn |
| Dec 31, 2013 | 3.10 Mn |
| Sep 30, 2013 | -1.07 Mn |